\
&
Contact us
\
&
Contact us
This was 6 days ago
LocationOnline
ProgrammesThis webinar is part of a workshop series under the FertiCovery project. It looks at stakeholder views on the market uptake, upscaling potential and replication potential of selected nutrient recovery and bio-based fertiliser technologies. The session is organised by the European Biogas Association, which leads part of the project work. FertiCovery looks in particular at nutrient recovery and the production of bio-based fertilisers from secondary raw materials such as biowaste, manure and wastewater.
This third workshop in the series is designed to gather feedback on 25 selected technologies. The discussion focuses on their upscaling potential and the regulatory frameworks that shape their use, including barriers and enablers linked to replication and market uptake. Participation is free and the event is only online. You can register here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
